Elucidation of fluoroaromatic-amino acid contacts between inhibitors and viral neuraminidase

被引：0
|
作者：
Jain, A [1 ]
Cantrell, KM [1 ]
Wong, I [1 ]
机构：
[1] Univ Calif Berkeley, Berkeley, CA 94720 USA
来源：
BIOCHEMISTRY | 2003年 / 42卷 / 28期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
160
引用
收藏
页码：8630 / 8630
页数：1
相关论文
共 41 条
  • [21] Y155H amino acid substitution in influenza A(H1N1) pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors
    Perez-Sautu, U.
    Pozo, F.
    Cuesta, I.
    Monzon, S.
    Calderon, A.
    Gonzalez, M.
    Molinero, M.
    Lopez-Miragaya, I.
    Rey, S.
    Canizares, A.
    Rodriguez, G.
    Gonzalez-Velasco, C.
    Lackenby, A.
    Casas, I.
    EUROSURVEILLANCE, 2014, 19 (27): : 14 - 20
  • [22] Amino acid changes in Gag that develop in vivo during protease inhibitor therapy have a dominant effect on viral replication and sensitivity to protease inhibitors ex vivo
    Koch, S.
    Coman, R.
    Munoz, I.
    Dunn, B. M.
    Sleasman, J. W.
    Goodenow, M. M.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S66 - S66
  • [23] STUDY ON THIOL PROTEASE INHIBITORS .4. RELATIONSHIP BETWEEN STRUCTURE AND PAPAIN INHIBITORY ACTIVITY OF EPOXYSUCCINYL AMINO-ACID DERIVATIVES
    TAMAI, M
    ADACHI, T
    OGUMA, K
    MORIMOTO, S
    HANADA, K
    OHMURA, S
    OHZEKI, M
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1981, 45 (03): : 675 - 679
  • [24] Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load
    Toyoda, Hidenori
    Kumada, Takashi
    Tada, Toshifumi
    Arakawa, Takahiro
    Hayashi, Kazuhiko
    Honda, Takashi
    Katano, Yoshiaki
    Goto, Hidemi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (06) : 1072 - 1078
  • [25] INTERACTIONS BETWEEN SINDBIS VIRUS RNAS AND A 68 AMINO-ACID DERIVATIVE OF THE VIRAL CAPSID PROTEIN FURTHER DEFINES THE CAPSID BINDING-SITE
    WEISS, B
    GEIGENMULLERGNIRKE, U
    SCHLESINGER, S
    NUCLEIC ACIDS RESEARCH, 1994, 22 (05) : 780 - 786
  • [26] Amino acid substitutions affecting aspartic acid 605 and valine 606 decrease the interaction strength between the influenza virus RNA polymerase PB2 '627' domain and the viral nucleoprotein
    Hsia, Ho-Pan
    Yang, Yin-Hua
    Szeto, Wun-Chung
    Nilsson, Benjamin E.
    Lo, Chun-Yeung
    Ng, Andy Ka-Leung
    Fodor, Ervin
    Shaw, Pang-Chui
    PLOS ONE, 2018, 13 (01):
  • [27] IN SILICO AMINO ACID CHARACTERISATION OF HEPATITIS E VIRUS ORF2 REVEALS VARIATIONS BETWEEN HUMAN, NON-HUMAN AND ZOONOTIC VIRAL GENOTYPES
    Berto, A.
    Ijaz, S.
    Tedder, R. S.
    Allen, D. J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S286 - S286
  • [28] The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors
    Kameoka, Masanori
    Isarangkura-na-ayuthaya, Panasda
    Kameoka, Yoko
    Sapsutthipas, Sompong
    Soonthornsata, Bongkot
    Nakamura, Shota
    Tokunaga, Kenzo
    Sawanpanyalert, Pathom
    Ikuta, Kazuyoshi
    Auwanit, Wattana
    VIROLOGY, 2010, 405 (01) : 129 - 138
  • [29] SUSCEPTIBILITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENZYME AND VIRAL VARIANTS EXPRESSING MULTIPLE RESISTANCE-ENGENDERING AMINO-ACID SUBSTITUTIONS TO REVERSE-TRANSCRIPTASE INHIBITORS
    BYRNES, VW
    EMINI, EA
    SCHLEIF, WA
    CONDRA, JH
    SCHNEIDER, CL
    LONG, WJ
    WOLFGANG, JA
    GRAHAM, DJ
    GOTLIB, L
    SCHLABACH, AJ
    WOLANSKI, BS
    BLAHY, OM
    QUINTERO, JC
    RHODES, A
    ROTH, E
    TITUS, DL
    SARDANA, VV
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) : 1404 - 1407
  • [30] AMINO-ACID-SEQUENCE ELUCIDATION OF HUMAN ACROSIN-TRYPSIN INHIBITOR (HUSI-II) REVEALS THAT KAZAL-TYPE PROTEINASE-INHIBITORS ARE STRUCTURALLY RELATED TO BETA-SUBUNITS OF GLYCOPROTEIN HORMONES
    FINK, E
    HEHLEINFINK, C
    EULITZ, M
    FEBS LETTERS, 1990, 270 (1-2) : 222 - 224
12345